Stiff Person Syndrome

Original Editor - Your name will be added here if you created the original content for this page.

Lead Editors  

Definition

Stiff person syndrome (SPS) is a rare acquired neurological disorder characterized by fluctuating muscle rigidity and stiffness, painful spasms, and continuous motor unit activity (1, 2, 3). This condition was originally described as “stiff man syndrome” (SMS) by Moersch and Woltman in 1956. They reported observations from 14 cases of patients who experienced progressive stiffness, episodic painful muscle spasms, and difficulty walking without any other neurological signs (4). The rigidity and continuous motor unit activity is most pronounced in muscles of the trunk (thoracolumbar paraspinals and rectus abdominis), but may also occur in the legs and arms, and persists even when relaxation is attempted (3).

SPS includes the following variants: classical SPS, focal SMS, Stiff Leg Syndrome (SLS), jerking SMS, progressive encephalomyelitis with rigidity and myoclonus (PERM) paraneoplastic SMS, gait ataxia, dysarthria, and abnormal eye movements (1, 3).

Etiology / Epidemiology

The exact etiology of SPS remains unclear, however it is widely accepted as an autoimmune disease (1, 2, 3, 4). The majority of SPS cases contain the glutamic acid decarboxylase (GAD) autoantibody. GAD is a GABA synthesizing enzyme, with two primary isoforms: GAD-65 and GAD-67 (1, 2). GAD-65 is primarily associated with SPS; it is also associated with diabetes mellitus, cerebellar ataxia, and limbic encephalitis (1). When GAD is inhibited by the anti-GAD in SPS, GABA becomes less readily available, thus reducing GABA’s inhibitory effect. This process leads to continuous stimulation of muscles by motor neurons, resulting in muscle rigidity (1, 3).

SPS is a very rare disease, prevalent in 1-2 in a million (1, 2). It is mostly reported in women, with 2 women affected per every one man (1, 5). SPS usually manifests later in life; the patient typically presents with initial symptoms between 40-60 years of age, although onset has been reported in patients younger and older (1, 3, 5). Over half of SPS patients have, or will develop, diabetes at some point. SPS is also related to thyroid disease and vitiligo (5).

Clinical Presentation

add text here relating to the clinical presentation of the condition

Diagnostic Procedures

add text here relating to diagnostic tests for the condition

Outcome Measures

add links to outcome measures here (see Outcome Measures Database)

Physical Therapy Management

It is important to note that physical therapy could worsen symptoms of SPS during certain phases of the disease, the efficacy of physical therapy is highly variable, and certain precautions should be taken before proceeding with treatments.

Scott Newsome, DO, Department of Neurology at Johns Hopkins Medical (2015) recommends that physical therapy involve:

• Deep tissue myofacial techniques
  
• Ultrasound
  
• Passive range of motion (any type of contractile exercise can reproduce or worsen symptoms), and
  
• Heat therapy or possibly hydrotherapy because any type of cold therapy can exacerbate symptoms
  
  

Ultimately, physical therapy should be tailored to the individual with SPS are people present differently with the disease. It is important to comply with patient goals, understand symptom triggers, and help in the best way possible to reduce pain, therefore increasing the quality of life in those living with SPS.

Differential Diagnosis

add text here relating to the differential diagnosis of this condition

Key Evidence

add text here relating to key evidence with regards to any of the above headings

Resources

add appropriate resources here

Case Studies

add links to case studies here (case studies should be added on new pages using the case study template)

References

References will automatically be added here, see adding references tutorial.